A critical breakthrough in cancer investigation is occurring with the use of mini-antibodies to reactivate damaged p53. This vital malignant inhibitor protein is frequently lost in various types of malignancies, https://bouchesocial.com/story24297993/vhh-fragments-restore-the-p53-protein-a-new-pathway-for-tumor-treatment